Key result
Older age in women correlates with ~65% greater cutaneous vasodilatation from low-dose nicotine.
Why the study?
The effect of ageing on muscarinic, nicotinic, and ATP-mediated cutaneous vasodilatation in women was unclear.
Does ageing augment muscarinic, nicotinic, and/or ATP-mediated cutaneous vasodilatation in healthy women?
Cross-Sectional (n=22)
Does ageing augment muscarinic, nicotinic, and/or ATP-mediated cutaneous vasodilatation in healthy women?
Ageing augments nicotinic and ATP-induced, but not muscarinic, cutaneous vasodilatation in healthy women, suggesting altered microvascular responsiveness with age.
May indicate altered microvascular responsiveness with ageing in women; leaves open effects on outcomes and requires prospective validation.
NEW FINDINGS: What is the central question of this study? Does ageing augment muscarinic, nicotinic and/or ATP-mediated cutaneous vasodilatation in women? What is the main finding and its importance? Ageing augments nicotinic and ATP-induced, but not muscarinic, cutaneous vasodilatation in women. This will stimulate future studies assessing the pathophysiological significance of the augmented microvascular responsiveness in older women compared to their young counterparts. ABSTRACT: We previously reported that ageing attenuates adenosine triphosphate (ATP)-induced, but not muscarinic and nicotinic, cutaneous vasodilatation in men, and that ageing may augment cutaneous vascular responses in women. In the present study, we evaluated the hypothesis that ageing augments muscarinic, nicotinic and/or ATP-mediated cutaneous vasodilatation in healthy women. In 11 young (23 ± 5 years) and 11 older (60 ± 8 years) women, cutaneous vascular conductance was evaluated at three forearm skin sites that were perfused with (1) methacholine (muscarinic receptor agonist, 5 doses: 0.0125, 0.25, 5, 100, 2000 mm), (2) nicotine (nicotinic receptor agonist, 5 doses: 1.2, 3.6, 11, 33, 100 mm), or (3) ATP (purinergic receptor agonist, 5 doses: 0.03, 0.3, 3, 30, 300 mm). Each agonist was administered for 25 min per dose. Methacholine-induced increases in cutaneous vascular conductance were not different between groups at all doses (all P > 0.05). However, a nicotine-induced elevation in cutaneous vascular conductance at the lowest concentration (1.2 mm) was greater in older vs. young women (43 ± 15 vs. 26 ± 10%max, P = 0.04). ATP-induced increases in cutaneous vascular conductance at moderate and high doses (3 and 30 mm) were also greater in older relative to young women (3 mm, 44 ± 11 vs. 28 ± 10%max, P = 0.02; 30 mm, 83 ± 14 vs. 64 ± 17%max, P = 0.05). Therefore, ageing augments nicotinic and ATP-induced, but not muscarinic, cutaneous vasodilatation in women.
No takes yet. Share an insight, caveat, or question.
Fujii et al. (2019) conducted a cross-sectional in Healthy (n=22). Older age (Ageing) vs. Young age was evaluated on Cutaneous vascular conductance in response to 1.2 mm nicotine (%max) (p=0.04). Older age augmented cutaneous vasodilatation in women in response to low-dose nicotine (43% vs 26% max, P=0.04) and moderate-to-high dose ATP, but not methacholine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: